Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» elbasvir/grazoprevir
elbasvir/grazoprevir
Merck’s ZEPATIER™ (Elbasvir and Grazoprevir) Showed Superiority on Efficacy and Safety Endpoints Compared to Sofosbuvir Plus Peginterferon and Ribavirin Treatment Regimen in Phase 3 Trial
Yahoo
Thu, 04/14/16 - 09:41 am
Merck
Zepatier
elbasvir/grazoprevir
hepatitis C
3 Things You Absolutely Must Know About Merck
Motley Fool
Tue, 01/12/16 - 02:30 pm
Merck
M&A
Keytruda
elbasvir/grazoprevir
Kenneth Frazier
3 Potential Blockbuster Drugs Launching in 2016
Investors.com
Wed, 01/6/16 - 10:57 am
Merck
hepatitis C
elbasvir/grazoprevir
Gilead Sciences
sofosbuvir/velpatasvir
Eli Lilly
psoriasis
ixekizumab
Merck’s Share Price Has Been Volatile on Impending Drug Approvals
Yahoo/Market Realist
Fri, 12/18/15 - 12:31 pm
Merck
elbasvir/grazoprevir
hepatitis C
Merck to Release Findings from Integrated Analysis of Six Phase 2 and 3 Clinical Trials Evaluating Investigational Elbasvir/Grazoprevir in Hepatitis C
Yahoo
Sun, 11/15/15 - 11:39 am
Merck
clinical trials
elbasvir/grazoprevir
hepatitis C
Merck HCV Treatment: The Next Big Breakthrough?
Bidness, ETC
Wed, 10/21/15 - 10:31 am
Merck
hepatitis C
elbasvir/grazoprevir
MK-36822
MK-84083